Specifically, carriers of at least one risk allele of either TNS1 rs918949 or NRXN1 rs10194978 who were exposed to ETS had the highest risk of developing the combined asthma–eczema phenotype compared with nonexposed children carrying the wild-type genotype (Table 5). This evidence concerns the gene NRXN1 and Eczematoid dermatitis.